The study involved data from 16,827 patients evaluated by neuro-ophthalmologists, and focused on patients with type 2 diabetes or those who were overweight or obese, comparing those prescribed semaglutide to those using non-glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications
Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: an updated meta-analysis
Some researchers combine Retatrutide with peptides like BPC-157 or TB-500 for additional recovery benefits, particularly when pursuing aggressive exercise alongside weight loss
You have heart disease plus type 2 diabetes, high blood pressure, or sleep apnea
Watch for persistent headaches that dont respond well to hydration alone, muscle cramps or weakness, unusual fatigue or brain fog, heart palpitations, worsening nausea despite dose stability, dizziness when standing up, and constipation that doesnt improve with fiber intake